Definitive Contract 75A50124C00051
Award Date
9/25/24
Potential Completion Date
6/30/27
Potential Value
$9.2M
Awardee
Lumos Diagnostics, Inc.
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Carlsbad, CA 92010, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $5,240,000.00 firm fixed price definitive contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency, to Lumiradx, Inc., a foreign-owned, for-profit organization. The contract is for Lumiradx to provide a SARS-CoV-2 & Flu A/B high sensitivity antigen assay under the RADX Tech program. The contract has an ultimate completion date of May 31, 2022 and was awarded on September 30, 2021. This contract is not associated with any set-aside designation.
<p>This is a $146,030 firm fixed-price purchase order awarded by the National Heart Lung and Blood Institute, a civilian federal agency, to LumiraDx, Inc., a for-profit foreign-owned company located in Waltham, Massachusetts. The award is for the finalization of a SARS-CoV-2 and influenza A/B test under the RADX TECH program. The contract has an ultimate completion date of July 20, 2023 and does not have a set-aside designation.</p>
This is a $749,000.00 firm fixed price definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian federal agency, to In Diagnostics, Inc. to develop endpoint and kinetic measurement capabilities on a low-cost, disposable spectrophotometer platform. The contract does not have a set-aside designation and is scheduled for completion by June 30, 2025. The awardee, In Diagnostics, Inc., is a for-profit organization located in Carlsbad, California.
<p>This is a $12,606,489.57 Firm Fixed Price definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian agency, to AD Astra Diagnostics, Inc. for the research and development of a CLIA-waived ubiquitous early sepsis detection and severity assessment system for use in ambulance, pre-hospital, and post-discharge settings. The contract has an ultimate completion date of December 15, 2027 and does not have a set-aside designation.</p>
This is a $24,631,080.00 definitive cost-reimbursement contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS) to Sapphiros LLC, a for-profit foreign-owned organization. The contract is for the advanced research and development of a low-cost, connected, digital lateral flow platform to detect influenza A, influenza B, and SARS-CoV-2 for use in over-the-counter (OTC) settings. This contract was...
This is a $52,239,640.00 definitive contract awarded to Visby Medical, Inc. by the U.S. Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response. The contract is for the delivery of a rapid, accurate, point-of-care disposable influenza and SARS-CoV-2 molecular diagnostic test. This award is not set aside for any particular business classification. The contract has an ultimate completion date of March 31, 2026. The original solicitation was issued...
Mbio Diagnostics Inc., doing business as Lightdeck Diagnostics, has been awarded a firm fixed-price purchase order valued at $5,654,478 by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response (HHS ASPR). The base period of performance for this contract is from February 3, 2021 through February 2, 2022. Under the contract, Lightdeck Diagnostics will develop its Lightdeck SARS-CoV Ultra-Rapid Antigen Test to achieve Emergency Use Authorization...
This is a $2,400,000.00 firm-fixed-price contract awarded by the U.S. Department of Health and Human Services (HHS), Administration for Strategic Preparedness and Response (ASPR), Center for Industrial Base Expansion and Supply Chain (IBMSC) to Watmind USA, Inc., a small disadvantaged business. The contract is to provide 1,000,000 commercial off-the-shelf multi-antigen diagnostic test kits capable of detecting SARS-CoV-2 and Influenza A/B. The objective is to ensure the government is...
This is a $27,992,718.00 definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian agency, to Inflammatix, Inc., a self-certified small disadvantaged business, for the development of a full stack of host-response solutions to address infectious disease testing for acute infections and sepsis. The contract is for the period of September 25, 2019 through May 7, 2027 and is a cost-sharing arrangement. No set-aside was used for this award....
This federal contract award was made by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Inflammatix, Inc., a small disadvantaged business. The $749,999 firm fixed-price contract supports research and development for the Triverity cartridge, a diagnostic tool focused on infection severity and sepsis detection, under Area of Interest #2 of ASPR's Easy Broad Agency Announcement. The...